OU Health Sciences Center Researcher Joins COVID-19 Vaccine Project
University of Oklahoma Health Sciences Center has launched a research collaboration with Pure MHC, an innovative biotechnology company, to work toward the development of a vaccine for the COVID-19 virus.
At the OU Health Sciences Center, the scientific team is led by William Hildebrand, Ph.D., whose expertise is helping the body’s protective immune cells target and kill virus-infected cells. He will be working with Pure MHC, part of a family of biotechnology companies formed, funded and managed by Emergent Technologies, Inc. Approximately 20 years ago, it commercialized and advanced Hildebrand’s and others’ research to develop break through drugs and therapies. This partnership represents a unique collaboration between researchers in a university setting and a company with the scientific expertise and investment to further the project.
Hildebrand’s research career has focused on a crucial component of vaccine development: creating targets that help the immune system’s T-cells find and kill virus-infected cells. Because COVID-19 is an entirely new virus, the body’s immune system has not been trained to recognize it. Hildebrand’s research discoveries could provide a target for a potential vaccine.
To read more please log in or subscribe to the digital edition https://etypeservices.com/The%20Okeene%20RecordID208/